Abstract
Positive impacts on human health can occasionally arise from adopting techniques and approaches developed for entirely different purposes. Mitochondrial replacement therapy (MRT), also referred to as mitochondrial donation, is an example. Its origins date back to the development of embryo micromanipulation techniques in the 1980s. These techniques, originally designed to investigate how the nucleus and cytoplasm interact to instruct the process of embryonic development, are now on the cusp of being introduced into the clinic as the only realistic hope for preventing the propagation of a debilitating set of genetic diseases. While there is little doubt that the risk associated with carrying out these long-established techniques is far outweighed by the clinical impact of preventing genetic disease, their adoption represents an unprecedented level of intervention in early human development. The authors reassess development of the technologies using a lens which may inform and improve their adoption into clinical practice.
Original language | English |
---|---|
Title of host publication | Reproduction Reborn |
Subtitle of host publication | How Science, Ethics, and Law Shape Mitochondrial Replacement Therapies |
Editors | Diana Bowman |
Place of Publication | United States |
Publisher | Oxford University Press, USA |
Chapter | 1 |
Pages | 17-31 |
Number of pages | 15 |
ISBN (Electronic) | 9780197616192 |
ISBN (Print) | 9780197616208 |
DOIs | |
Publication status | Published - Feb 2023 |
Keywords
- clinical practice
- epigenetic consequences
- genetic disease
- mitochondrial DNA mutations
- mitochondrial donation
- mitochondrial replacement therapy
- phenotypic alterations